Empresa ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Acciones
1541
CNE100006624
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
14,9 HKD | -0,53 % | +1,09 % | -50,17 % |
Resumen de negocios
Número de empleados: 145
Ventas por actividad
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cell Strain and Other Products
95,1
%
| 1 | 92,8 % | 0 | 95,1 % | -30,11 % |
Testing Services
4,9
%
| 0 | 7,2 % | 0 | 4,9 % | -53,71 % |
Ventas por región
HKD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -31,82 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Wen Zhi Tian
CEO | Chief Executive Officer | - | 01/06/15 |
Qi Ying Lu
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/22 |
Song Li
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/15 |
Zikai Xiong
PRN | Corporate Officer/Principal | - | 01/03/22 |
Ru liang Zhang
PRN | Corporate Officer/Principal | - | 01/02/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Chi Tat Yeung
BRD | Director/Board Member | 55 | - |
Zhi Hua Yu
BRD | Director/Board Member | 56 | - |
Wen Zhi Tian
CEO | Chief Executive Officer | - | 01/06/15 |
Zhenping Zhu
BRD | Director/Board Member | - | - |
Xiao Yong Yu
BRD | Director/Board Member | 51 | - |
Song Li
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/15 |
Cong Xu
BRD | Director/Board Member | - | - |
Kendall Smith
BRD | Director/Board Member | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 228 550 039 | 69 612 628 ( 30,46 %) | 0 | 30,46 % |
Información de la empresa
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd.
Building 15, Lane 1000 Zhangheng Road
200120, Zhangjiang Science City
+86 21 3801 6387
http://cn.immuneonco.comSector
Ventas por actividad
Chiffre d''affaires - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-50,17 % | 717 M | |
+2,93 % | 108 mil M | |
+8,82 % | 105 mil M | |
+1,08 % | 23,46 mil M | |
-14,60 % | 21,72 mil M | |
-7,05 % | 18,64 mil M | |
-38,55 % | 17,45 mil M | |
-8,83 % | 17,19 mil M | |
+5,51 % | 13,99 mil M | |
+37,49 % | 12,53 mil M |
- Bolsa de valores
- Acciones
- Acción 1541
- Empresa ImmuneOnco Biopharmaceuticals (Shanghai) Inc.